Home › Funds › Patient Capital Management, LLC › SDRL
Patient Capital Management, LLC position in SDRL
SEADRILL LTD · Energy
Patient Capital Management, LLC reported holding 1,901,982 shares of SDRL (SEADRILL LTD) in its Q3 2026 13F filing — a position valued at US$85.0M, representing 2.87% of its reported portfolio and ranking #17 among its reported holdings. Patient Capital Management, LLC has disclosed SDRL holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Capital Management, LLC's SDRL position evolved
Patient Capital Management, LLC first disclosed a stake in SDRL in Q4 2023 at 662,574 shares (US$31.3M). The position peaked in Q1 2026 at 2,152,685 shares, worth US$97.9M. Across 12 filings, Patient Capital Management, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,901,982 shares valued at US$85.0M — a reduction of -51,373 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2024 (shares rose 2% over the following quarter), a 63% increase in Q4 2024 (shares fell 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 662.57K | $31.33M | New |
| Q1 2024 | 900.31K | $45.29M | Add |
| Q2 2024 | 907.60K | $46.74M | Add |
| Q3 2024 | 1.03M | $40.76M | Add |
| Q4 2024 | 1.68M | $65.28M | Add |
| Q1 2025 | 1.97M | $49.32M | Add |
| Q2 2025 | 2.23M | $58.53M | Add |
| Q3 2025 | 2.23M | $67.37M | Hold |
| Q4 2025 | 2.05M | $71.06M | Reduce |
| Q1 2026 | 2.15M | $97.95M | Add |
| Q2 2026 | 1.95M | $73.88M | Reduce |
| Q3 2026 | 1.90M | $84.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SDRL and 13F data
SDRL (SEADRILL LTD) is a Energy company. 29 other funds we track also report a position in SDRL — the largest reported positions include Elliott Investment Management (US$167.9M), Goehring & Rozencwajg Associates, LLC (US$99.7M), Webs Creek Capital Management LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SDRL
- Elliott Investment Management 4.44M sh · $167.91M · Q2 2026
- Goehring & Rozencwajg Associates, LLC 2.64M sh · $99.72M · Q2 2026
- Webs Creek Capital Management LP 1.31M sh · $49.37M · Q2 2026
- Condire Management, LP 1.28M sh · $48.41M · Q2 2026
- Sagefield Capital LP 856.54K sh · $32.39M · Q2 2026
- Hosking Partners LLP 677.64K sh · $30.27M · Q3 2026
- Packer & Co Ltd 613.08K sh · $27.39M · Q3 2026
More on Patient Capital Management, LLC
FAQ
How long has Patient Capital Management, LLC held SDRL?
Patient Capital Management, LLC has disclosed SDRL holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Patient Capital Management, LLC's current position in SDRL?
As of Q3 2026, Patient Capital Management, LLC holds 1.90M shares of SDRL (SEADRILL LTD), valued at $84.96M, representing 2.87% of its reported portfolio and ranking #17.
Has Patient Capital Management, LLC been buying or selling SDRL?
In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in SDRL. The position peaked in Q1 2026 at 2.15M shares.
Which other funds hold SDRL?
Other major institutional holders of SDRL include Elliott Investment Management, Goehring & Rozencwajg Associates, LLC, Webs Creek Capital Management LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.